QR Code

Isolation of anti-tumor monoclonal antibodies targeting on MICA/B α3 domain by single B cell technology for colon cancer therapy

Colon cancer (CC) is one of the most common gastrointestinal malignancies. Effectiveness of the existing therapies is limited. Immunotherapy is a promising complementary treatment approach for CC. Major histocompatibility complex class I-related protein A and B (MICA/B) are ligands for NK cells. She...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Xueyi Tang, Linhai He, Xiaoli Wang, Shuaichao Liu, Xiangning Liu, Xiaorui Shen, Yun Shu, Ke Yang, Qionghua Zhou, Zujian Shan, Yueming Wang, Changwen Wu, Zhenxing Jia, Tong Liu, Yayu Wang, Hua-Xin Liao, Yun Xia
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2024-08-01
Rangatū:Heliyon
Ngā marau:
Colon cancer
MICA/B
Natural killer group 2D ligand
Immunotherapy
Natural killer group 2D receptor
Antibody screening technology
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2405844024117288
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite